Cargando…
Dual use of antifungals in medicine and agriculture: How do we help prevent resistance developing in human pathogens?
Azole resistance in Aspergillus fumigatus is a One Health resistance threat, where azole fungicide exposure compromises the efficacy of medical azoles. The use of the recently authorized fungicide ipflufenoquin, which shares its mode-of-action with a new antifungal olorofim, underscores the need for...
Autores principales: | Verweij, Paul E., Arendrup, Maiken C., Alastruey-Izquierdo, Ana, Gold, Jeremy A.W., Lockhart, Shawn R., Chiller, Tom, White, P.Lewis |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10693676/ https://www.ncbi.nlm.nih.gov/pubmed/36283187 http://dx.doi.org/10.1016/j.drup.2022.100885 |
Ejemplares similares
-
Molecular mechanisms of acquired antifungal drug resistance in principal fungal pathogens and EUCAST guidance for their laboratory detection and clinical implications
por: Rogers, Thomas R, et al.
Publicado: (2022) -
The challenges of the genome-based identification of antifungal resistance in the clinical routine
por: Alastruey-Izquierdo, Ana, et al.
Publicado: (2023) -
Fatal Fungicide-Associated Triazole-Resistant Aspergillus fumigatus Infection, Pennsylvania, USA
por: Bradley, Kennedy, et al.
Publicado: (2022) -
Ibrexafungerp: A Novel Oral Triterpenoid Antifungal in Development for the Treatment of Candida auris Infections
por: Ghannoum, Mahmoud, et al.
Publicado: (2020) -
Trends in Agricultural Triazole Fungicide Use in the United States, 1992–2016 and Possible Implications for Antifungal-Resistant Fungi in Human Disease
por: Toda, Mitsuru, et al.
Publicado: (2021)